JB Accepts, published online ahead of print on 18 October 2013 J. Bacteriol. doi:10.1128/JB.00750-13 Copyright © 2013, American Society for Microbiology. All Rights Reserved. Bacterial secretins form constitutively open pores akin to general (cid:883) porins (cid:884) Elena Disconzi1,2,3,4, Ingrid Guilvout3,4, Mohamed Chami5, Muriel Masi1,2, Gerard H. M. (cid:885) Huysmans3,4, Anthony P. Pugsley3,4 and Nicolas Bayan1,2# D o (cid:886) w n lo a (cid:887) d 1 Université de Paris-Sud, Institut de Biochimie et de Biophysique Moléculaire et Cellulaire, e d f (cid:888) r o Orsay, France m h (cid:889) t 2 Centre National de la Recherche Scientifique UMR 8619, Orsay, France. tp : / / jb (cid:890) . 3 Institut Pasteur, Molecular Genetics Unit, rue du Dr. Roux Paris 15, France. a s m (cid:891) . o 4 Centre National de Recherche Scientifique ERA3625, rue du Dr. Roux Paris 15, France. r g / (cid:883)(cid:882) o 5 C-CINA Center For Imaging and NanoAnalytics, Biozentrum, University of Basel, CH n D e (cid:883)(cid:883) 4058 Basel, Switzerland c e m (cid:883)(cid:884) b e r 2 (cid:883)(cid:885) 5 , #To whom correspondence should be addressed: Nicolas Bayan, IBBMC, Bât 430, Université 2 0 1 (cid:883)(cid:886) de Paris-Sud, 91405 Orsay cedex. Tel: (33) 1 69 15 36 10, Fax: (33) 1 69 85 37 15, e-mail: 8 b (cid:883)(cid:887) [email protected] y g u (cid:883)(cid:888) e s t (cid:883)(cid:889) Running title: Secretin pore size (cid:883)(cid:890) Keywords: liposomes, pore forming protein, reconstitution, leakage assay, cell-free protein (cid:883)(cid:891) synthesis (cid:884)(cid:882) (cid:883) (cid:884)(cid:883) Abstract (cid:884)(cid:884) Proteins called secretins form large multimeric complexes that are essential for (cid:884)(cid:885) macromolecular transit across the outer membrane of Gram-negative bacteria. Evidence D o w (cid:884)(cid:886) suggests that the channels formed by some secretin complexes are not tightly closed, but their n lo a (cid:884)(cid:887) permeability properties have not been well characterized. Here, we used cell-free synthesis d e d (cid:884)(cid:888) coupled with spontaneous insertion into liposomes to investigate the permeability of the f r o m (cid:884)(cid:889) secretin PulD. Leakage assays using preloaded liposomes indicated that PulD allows the h t (cid:884)(cid:890) efflux of small fluorescent molecules with a permeation cut-off similar to that of general tp : / / (cid:884)(cid:891) porins. Other secretins were also found to form similar pores. To define the polypeptide jb . a s (cid:885)(cid:882) region involved in determining the pore size, we analyzed a collection of PulD variants and m . o (cid:885)(cid:883) studied the roles of Gates 1 and 2, previously reported to affect the pore size of filamentous rg / o (cid:885)(cid:884) phage f1 secretin pIV, in assembly and pore formation. Liposome leakage and a novel in vivo n D (cid:885)(cid:885) assay showed that substitution of the conserved proline residue at position 443 in PulD by e c e m (cid:885)(cid:886) leucine increased the apparent size of the pore. The in vitro approach described here could be b e r (cid:885)(cid:887) used to study the pore properties of membrane proteins whose production in vivo is toxic. 2 5 , (cid:885)(cid:888) 2 0 1 8 (cid:885)(cid:889) Abbreviations b y g (cid:885)(cid:890) u OM: outer membrane; T2SS: type II secretion system; T3SS: type III secretion system; T4P: e s t (cid:885)(cid:891) type 4 pilus assembly; PulDfl: full-length PulD; PulD28-42/259-660: truncated PulD consisting of (cid:886)(cid:882) residues 28-42/259-660. (cid:886)(cid:883) (cid:886)(cid:884) (cid:886)(cid:885) (cid:884) (cid:886)(cid:886) (cid:886)(cid:887) D o w n lo a d e d f r o m h t t p : / / jb . a s m . o r g / o n D e c e m b e r 2 5 , 2 0 1 8 b y g u e s t (cid:885) Introduction (cid:886)(cid:888) Multi-domain proteins called secretins form large outer membrane (OM) complexes that act (cid:886)(cid:889) as portals for protein (e.g., PulD, OutD, XcpQ) and filamentous bacteriophage (e.g., pIV) (cid:886)(cid:890) secretion, for DNA uptake and type IV pilus assembly (T4P; e.g., PilQ) and for needle (cid:886)(cid:891) assembly and protein secretion in type III secretion systems (T3SS) in Gram-negative bacteria D o w (cid:887)(cid:882) (1). Cryo-electron microscopy of the archetypical type II secretion system (T2SS) secretin n lo a (cid:887)(cid:883) PulD from Klebsiella oxytoca revealed how twelve protomers arrange in a barrel-like d e d (cid:887)(cid:884) complex of dodecameric symmetry with an open, outwards-facing ring connected to a second f r o (cid:887)(cid:885) ring creating a vestibule deep into the periplasm (2). A plug closes off the barrel near its m h t (cid:887)(cid:886) center. Other secretins have a similar architecture (3-5), but the structure of the membrane- tp : / / (cid:887)(cid:887) embedded part of the complex, including the plug, has not been reported at atomic resolution. jb . a s (cid:887)(cid:888) m Other approaches have begun to reveal molecular details of secretin architecture. All secretins . o r g (cid:887)(cid:889) share a common domain organization comprising a well-conserved C domain, which includes / o n (cid:887)(cid:890) the afore-mentioned gated membrane channel, and a less well conserved N domain that D e (cid:887)(cid:891) consists of up to four globular domains named N0 to N3, all of which are present in the ce m (cid:888)(cid:882) prototype secretin PulD (Fig. 1A). The N domain is located in the periplasm and interacts b e r (cid:888)(cid:883) with inner membrane components of the secretion machinery (6-9). The atomic resolution 2 5 , 2 (cid:888)(cid:884) structures of part of the N domains of several secretins have been solved by X-ray 0 1 8 (cid:888)(cid:885) crystallography (T3SS: EscC (10) and T2SS: GspD (11) and XcpQ (12)) and NMR b y (cid:888)(cid:886) spectroscopy (T4P: EscC (13)). Some secretins, including PulD, possess a C-terminal g u e s (cid:888)(cid:887) extension (S domain; Fig. 1A) that interacts with a dedicated chaperone (PulS in the case of t (cid:888)(cid:888) PulD) that protects it from degradation and promotes correct localization (14, 15). In PulD, (cid:888)(cid:889) the C and S domains and the last of three periplasmic repeat domains (N ) (Fig. 1A) are 3 (cid:888)(cid:890) sufficient for targeting to- and insertion as a multimer into the OM (16). (cid:888)(cid:891) (cid:886) The plug in the ≥6 nm-wide secretin channel presumably blocks the release of periplasmic (cid:889)(cid:882) proteins when the secretin channel is in its resting state, i.e., when proteins or phages are not (cid:889)(cid:883) being secreted and pili or needles are not assembled. However, the secretin channel is not (cid:889)(cid:884) necessarily tightly closed. Several studies investigated the ability of reconstituted (resting (cid:889)(cid:885) state) secretins to form pores or channels in non-native lipid bilayers. Data from conductance D o (cid:889)(cid:886) measurements were sometimes difficult to interpret. High currents were measured upon w n (cid:889)(cid:887) reconstitution of the Pseudomonas aeruginosa secretin XcpQ in artificial membranes (17). lo a d e (cid:889)(cid:888) Large structural fluctuations in XcpQ were proposed to cause the observed non-uniform d f r (cid:889)(cid:889) conductance, which was very high compared to porins, did not increase linearly with the o m h (cid:889)(cid:890) applied potential and even persisted when the applied potentials were high. The Yersinia t t p : (cid:889)(cid:891) enterocolitica secretin YscC formed stable conductance channels when reconstituted in vitro, // jb . a (cid:890)(cid:882) but did not facilitate uptake of β-lactam antibiotics in vivo, indicative of a narrow molecular s m . (cid:890)(cid:883) weight cut-off (18). In contrast, PulD reconstituted into artificial bilayers only showed o r g / (cid:890)(cid:884) fluctuating conductance when a high voltage was applied across the lipid bilayer (19), o n D (cid:890)(cid:885) suggesting that it is normally in a tightly closed conformation. However, while PulD e c e (cid:890)(cid:886) produced in vivo in the presence of its chaperone PulS inserts in the outer membrane without m b e (cid:890)(cid:887) dramatically modifying its permeability, in the absence of PulS, it mislocalizes into the inner r 2 5 (cid:890)(cid:888) membrane and induces a phage shock response (16). This phenomenon suggests that PulD , 2 0 (cid:890)(cid:889) forms a proton-permeable pore in the inner membrane. Electrophysiology studies also 1 8 b (cid:890)(cid:890) suggested that the pIV secretin channel is tightly closed in vitro, although it allows an y g u (cid:890)(cid:891) Escherichia coli strain lacking maltoporin (LamB) to grow on small maltodextrins (20). The e s t (cid:891)(cid:882) permeability of the pIV channel was increased by changes in the pIV sequence that allowed a (cid:891)(cid:883) LamB-deficient strain to regain its ability to import maltopentose (21). These sequence (cid:891)(cid:884) changes clustered mainly in two regions that were named Gates 1 and 2 because of their (cid:891)(cid:885) proposed role in channel gating (21). To simplify the terminology, we will use the term (cid:891)(cid:886) (cid:887) secretin channel to define the wide-open conduit that permits protein or phage egress from the (cid:891)(cid:887) cell, and the term secretin pore to define the (hypothetical) partially closed conduit. The (cid:891)(cid:888) existence and properties of a pore in a resting state secretin complex are the subjects of this (cid:891)(cid:889) report. (cid:891)(cid:890) Many membrane proteins, including PulD and some other secretins, can be efficiently D o w (cid:891)(cid:891) synthesized and assembled into liposomes in a cell-free system (22-24). Here, we investigated n lo a (cid:883)(cid:882)(cid:882) the permeability properties of PulD, XcpQ, OutD and pIV inserted into liposomes preloaded d e d (cid:883)(cid:882)(cid:883) with small reporter molecules. A miniaturized version of the assay was used to screen a f r o m (cid:883)(cid:882)(cid:884) previously characterized PulD mutant library to identify residues influencing pore size (24, h t (cid:883)(cid:882)(cid:885) 25). tp : / / (cid:883)(cid:882)(cid:886) jb .a s m (cid:883)(cid:882)(cid:887) . o Materials and Methods r g / (cid:883)(cid:882)(cid:888) o n Bacterial strains and growth conditions D e c (cid:883)(cid:882)(cid:889) e m E. coli K-12 PAP105 [Δ(lac-pro) F' (lacIq1 ΔlacZM15 proAB+ Tn10)], used for plasmid b e r (cid:883)(cid:882)(cid:890) manipulations and E. coli PAP7447 [MC4100 (F' lacIq pro+ Tn10)], with pulS, pulA, and 2 5 , (cid:883)(cid:882)(cid:891) pulC-O integrated into malPp and with a large deletion in pulD, were grown in LB medium at 2 0 1 (cid:883)(cid:883)(cid:882) 30°C. E. coli strain NB190 (26) lacking cyanocobalamin receptor BtuB (proC22, trpE23, 8 b y (cid:883)(cid:883)(cid:883) metE70, lysA23, rpoB308, thi-1, lacZ36, xyl-5, mtl-1, rpsL109, cyc-19, tsx-67, supE44, (cid:507)btuB g u e (cid:883)(cid:883)(cid:884) arg F’ (lacIq1 ΔlacZM15 proAB Tn10)) was maintained in LB medium at 30°C. s + t (cid:883)(cid:883)(cid:885) Cyanocobalamin permeability assays with this strain were performed in 0.2% glucose M63B1 (cid:883)(cid:883)(cid:886) minimal medium (0.4 % maltose in experiments with pCHAP1226) supplemented with all (cid:883)(cid:883)(cid:887) amino acids except methionine and cysteine. Ampicillin (100 (cid:541)g/ml), chloramphenicol (25 (cid:883)(cid:883)(cid:888) (cid:541)g/ ml) and kanamycin (50 (cid:541)g/ ml) were used when appropriate. 5 (cid:541)g/ml of tetracycline was (cid:883)(cid:883)(cid:889) (cid:888) used to maintain the F’ in NB190, PAP105 and PAP7447. Staphylococcus aureus RN4220 (cid:883)(cid:883)(cid:890) was grown in LB medium (27) at 37°C. Cloning experiments were all done in PAP105 at 30 (cid:883)(cid:883)(cid:891) °C. (cid:883)(cid:884)(cid:882) Gene constructions and plasmids D (cid:883)(cid:884)(cid:883) o Plasmids and primers used in this study are listed in Table S1 and S2, respectively. w n lo (cid:883)(cid:884)(cid:884) pCHAP3674 and pCHAP3675 carrying wild type fhuA and fhuAΔ322-355, respectively, were a d e (cid:883)(cid:884)(cid:885) obtained by excision of the genes from pHK763 (28) and pHK226 (29), respectively, using d f r o (cid:883)(cid:884)(cid:886) EcoRI and HindIII and inserted into pBGS19 digested with the same enzymes. m h (cid:883)(cid:884)(cid:887) pCHAP3909, encoding α-hemolysin with a C-terminal His-tag, was obtained in a two-step tt p : / (cid:883)(cid:884)(cid:888) cloning reaction. pCHAP3908 was first obtained by ligation of a BlpI and BglII fragment /jb . a (cid:883)(cid:884)(cid:889) from pT7-HL (30) into pIVEX2.3MCS digested with the same enzymes. A hexahistidine tag s m . o (cid:883)(cid:884)(cid:890) was then introduced using primers ING163 and ING164 on pCHAP3908. The resulting r g / (cid:883)(cid:884)(cid:891) fragment was cleaved using NdeI and BamHI and ligated into pIVEX2.3MCS cleaved with o n D (cid:883)(cid:885)(cid:882) the same endonucleases. e c e (cid:883)(cid:885)(cid:883) Erwinia carotovora outD was amplified from pCPP2242 (31) with primers ING206 and m b e (cid:883)(cid:885)(cid:884) ING207, digested with NdeI and BamHI and ligated into pIVEX2.3MCS cleaved by the same r 2 5 (cid:883)(cid:885)(cid:885) enzymes to give pCHAP9718. , 2 0 (cid:883)(cid:885)(cid:886) The linker deletion in Dickeya dadantii OutD was created stepwise. The outD fragments up- 1 8 b (cid:883)(cid:885)(cid:887) and down-stream of residues 297-353 were amplified by PCR from pCHAP3794 using y g u (cid:883)(cid:885)(cid:888) primers ING86 and DIS26 and DIS27 and ING91, in which DIS26 and 27 have overlapping e s t (cid:883)(cid:885)(cid:889) termini. Both halves were assembled together by a second PCR reaction using ING86 and (cid:883)(cid:885)(cid:890) ING91. The resulting amplicon was cloned into pIVEX2.3MCS after digestion with NdeI and (cid:883)(cid:885)(cid:891) SacI. Additional mutations introduced by the primers DIS26 and DIS27 were corrected by (cid:883)(cid:886)(cid:882) site directed mutagenesis. (cid:883)(cid:886)(cid:883) (cid:889) pCHAP9724 containing a P252L substitution in the filamentous phage secretin pIV was (cid:883)(cid:886)(cid:884) obtained by mutagenesis using pCHAP9147 (24) and primers DIS43 and DIS44. (cid:883)(cid:886)(cid:885) PulD28-42/259-660ΔGate2 (pCHAP9715) was constructed from pCHAP3716 in two PCR steps. (cid:883)(cid:886)(cid:886) First, two fragments were generated using primers ING59 and DIS22 and primers ING62 and (cid:883)(cid:886)(cid:887) DIS23. In a second step, both amplified fragments were used as templates in a third reaction D o w (cid:883)(cid:886)(cid:888) with primers ING59 and ING62. The resulting amplicon was inserted in the plasmid pIVEX n lo a (cid:883)(cid:886)(cid:889) 2.3MCS digested with NdeI and BamHI. PulD28-42/259-660ΔGate1 (pCHAP9722) was d e d (cid:883)(cid:886)(cid:890) constructed by using the same procedure as the one described for PulD28-42/259-660ΔGate2 using f r o m (cid:883)(cid:886)(cid:891) primers DIS39 and DIS40 instead of DIS22 and DIS23. h t t (cid:883)(cid:887)(cid:882) p : Sac7d was amplified by PCR from pQUANTagen sac7d-phoA (32) using primers ING218 // jb . (cid:883)(cid:887)(cid:883) and ING219. The amplicon and pASK2C (IBA), encoding for an OmpA signal peptide and a a s m (cid:883)(cid:887)(cid:884) Strep-tag at opposite sides of the multiple cloning site, were digested with EcoRI and PstI and .o r g / (cid:883)(cid:887)(cid:885) ligated together to form pCHAP3978. The fragment containing the sequence for Sac7d with o n (cid:883)(cid:887)(cid:886) an N-terminal OmpA signal peptide and a C-terminal Strep tag was then subcloned in D e c (cid:883)(cid:887)(cid:887) pASK12 (IBA) using the XbaI/HindIII restriction sites to give pCHAP9725. e m b (cid:883)(cid:887)(cid:888) All constructions were verified by DNA sequencing e r 2 (cid:883)(cid:887)(cid:889) 5 , Preparation of liposomes 2 0 1 (cid:883)(cid:887)(cid:890) 8 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC; Avanti Polar Lipids) dissolved in b y g (cid:883)(cid:887)(cid:891) chloroform was dried under a stream of nitrogen. The resulting thin lipid film was hydrated u e s t (cid:883)(cid:888)(cid:882) with different buffered solutions (50 mM TrisCl pH 7.4) containing 50 mM disodium calcein, (cid:883)(cid:888)(cid:883) 10 mM carboxyfluorescein or 100 mg/ml of vancomycin. Carboxyfluorescein was added (cid:883)(cid:888)(cid:884) from a stock solution of 0.4 M in dimethyl sulfoxide. Multilamellar liposomes were probe- (cid:883)(cid:888)(cid:885) sonicated three times for 2 min (with 1 min intervals on ice) at 50% duty cycle and at an (cid:883)(cid:888)(cid:886) (cid:890) output of 3 using a Sonics Vibracell sonicator. Liposomes were predominantly unilamellar (cid:883)(cid:888)(cid:887) when examined by electron microscopy. Non-encapsulated compounds were removed by (cid:883)(cid:888)(cid:888) dialysis (Spectra/Por membrane; MWCO 6-8 kDa) at 4°C against three changes of 2 L of 50 (cid:883)(cid:888)(cid:889) mM TrisCl (pH 7.4). Liposomes were collected by centrifugation at 35000 x g for 15 min and (cid:883)(cid:888)(cid:890) resuspended in the same buffer to a final concentration of 25 mg/ml D o (cid:883)(cid:888)(cid:891) w In vitro synthesis and purification of α-hemolysin n lo a (cid:883)(cid:889)(cid:882) d e His-tagged α-hemolysin was synthesized for 24h at 30°C by adding pCHAP3909 (10 µg) to d f r o (cid:883)(cid:889)(cid:883) the RTS500 E. coli HY in vitro transcription/translation system (5 PRIME). The reaction was m h (cid:883)(cid:889)(cid:884) diluted in 25 mM phosphate buffer, pH 8, and applied to a Ni-NTA column (1 ml; Qiagen) tt p : / (cid:883)(cid:889)(cid:885) equilibrated with the same buffer. After washing with 10 column volumes of the same buffer, /jb . a (cid:883)(cid:889)(cid:886) α-hemolysin was eluted with the same buffer containing 250 mM imidazole. Imidazole was s m . o (cid:883)(cid:889)(cid:887) removed by dialysis against the same buffer before the protein was concentrated on an r g / (cid:883)(cid:889)(cid:888) Amicon ultra-4 centrifugal filter (Millipore). Protein purity was verified by SDS-PAGE. o n D (cid:883)(cid:889)(cid:889) e c Calcein release by purified α-hemolysin e m b (cid:883)(cid:889)(cid:890) e Calcein fluorescence was excited at 490 nm and the emission was monitored at 520 nm in an r 2 5 (cid:883)(cid:889)(cid:891) Infinitive F200 Pro Tecan spectrofluorometer. To initiate leakage, 3 µg of α-hemolysin was , 2 0 1 (cid:883)(cid:890)(cid:882) added to 15 µl of 50 mM TrisCl buffer (pH 7.4) containing 0.5 M sucrose (to enable 8 b y (cid:883)(cid:890)(cid:883) comparison with MscL leakage) and 50 µg of calcein-loaded liposomes. The reaction was g u e (cid:883)(cid:890)(cid:884) performed in 384-well plates (black, flat bottom, Greiner) at 30°C with continuous shaking. s t (cid:883)(cid:890)(cid:885) The total calcein amount in the liposomes was indicated by the fluorescence observed upon (cid:883)(cid:890)(cid:886) the addition of 0.1% Triton X-100. Fluorescence (determined every 90 seconds) was plotted (cid:883)(cid:890)(cid:887) as the percentage of the total calcein present in the reaction. (cid:883)(cid:890)(cid:888) (cid:891) Calcein and carboxyfluorescein release during in vitro synthesis of α-hemolysin or (cid:883)(cid:890)(cid:889) secretins (cid:883)(cid:890)(cid:890) Plasmid DNA (150 ng) and calcein- or carboxyfluorescein-loaded liposomes (50 µg) were (cid:883)(cid:890)(cid:891) added to 15 µl of the RTS100 E. coli HY reaction kit (5 PRIME). In vitro synthesis was D (cid:883)(cid:891)(cid:882) performed in 384-well plates (black, flat bottom, Greiner), and incubated in a o w n (cid:883)(cid:891)(cid:883) spectrofluorometer as above at 30°C with continuous shaking. Calcein and lo a d (cid:883)(cid:891)(cid:884) carboxyfluorescein were excited at 490 nm and 485 nm and the fluorescence emission was e d f (cid:883)(cid:891)(cid:885) monitored at 520 nm and 513 nm, respectively. The fluorescence signal was measured every r o m (cid:883)(cid:891)(cid:886) 15 min for 2 hours or every 90 s for 2 hours in initial experiments with α-hemolysin. The total h t t p (cid:883)(cid:891)(cid:887) amount of liposome-encapsulated dye was indicated by the fluorescence measured upon the :/ / jb (cid:883)(cid:891)(cid:888) addition of 0.1% Triton X-100 at the end of the reaction. Fluorescence was plotted as a .a s m (cid:883)(cid:891)(cid:889) percentage of total unquenched fluorescence. . o r g (cid:883)(cid:891)(cid:890) / Calcein release after in vitro synthesis of MscL on D (cid:883)(cid:891)(cid:891) e c Plasmid DNA (150 ng) encoding MscL (33) was added to 15 µl of the RTS100 E. coli HY e m b (cid:884)(cid:882)(cid:882) reaction kit supplemented with 50 µg calcein-loaded liposomes. The reaction mixture was e r 2 (cid:884)(cid:882)(cid:883) incubated for 5 h at 30°C. Under these conditions, MscL inserts in the liposome in a closed 5 , 2 (cid:884)(cid:882)(cid:884) conformation (iso-osmotic conditions) and no calcein leakage occurs. Following MscL 0 1 8 (cid:884)(cid:882)(cid:885) synthesis, 2 (cid:541)l aliquots of the reaction mixture were diluted into 990 (cid:541)l of 50 mM TrisCl (pH b y g (cid:884)(cid:882)(cid:886) 7.4) with or without 0.5 M sucrose. Calcein release is instantaneous and was measured u e s (cid:884)(cid:882)(cid:887) immediately after mixing. The samples were excited at 490 nm and emission scans were t (cid:884)(cid:882)(cid:888) monitored from 500 to 600 nm in a cuvette with path length of 1 cm in a Varian Cary Eclipse (cid:884)(cid:882)(cid:889) fluorescence spectrophotometer. Buffer spectra were subtracted. (cid:884)(cid:882)(cid:890) Vancomycin release (cid:884)(cid:882)(cid:891) (cid:883)(cid:882)
Description: